With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degrades, and many more assets, rejoining forces at the 7th TPD & Induced Proximity Summit has never been more important.

• The basics of TPD and fundamental principles underpinning induced proximity, PROTACs, and molecular glue functionality and application during the Bootcamp day.
• First-class insight and new data across every stage of the drug development timeline, split into 3 tracks Discovery, Preclinical, and Translational/Clinical.
• A look to the future, with a collection of the field’s forward thinkers pushing the boundaries.

Beacon TPD has the privilege of joining the community once again to deliver not just one, but two insightful talks, documenting the research and commercial landscapes. You can find further details of Katie Spooner‘s Research Analyst presentation here.